Core Viewpoint - Ardent Health, Inc. reported quarterly earnings of $0.52 per share, exceeding the Zacks Consensus Estimate of $0.30 per share, and showing an increase from $0.35 per share a year ago, indicating a strong earnings surprise of +73.33% [1] Financial Performance - The company achieved revenues of $1.65 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 7.91%, compared to $1.47 billion in the same quarter last year [2] - Over the last four quarters, Ardent Health has exceeded consensus EPS estimates three times and topped revenue estimates two times [2] Stock Performance - Ardent Health shares have declined approximately 39.6% since the beginning of the year, contrasting with the S&P 500's gain of 7.6% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating expectations of underperformance in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.72 on revenues of $1.63 billion, and for the current fiscal year, it is $1.92 on revenues of $6.33 billion [7] - The outlook for the Medical Services industry, where Ardent Health operates, is currently in the top 35% of Zacks industries, suggesting potential for better performance compared to lower-ranked industries [8]
Ardent Health, Inc. (ARDT) Q2 Earnings and Revenues Surpass Estimates